Quarterly report pursuant to Section 13 or 15(d)

Schedule of Reconciliation of Liabilities Measured at Fair Value (Details)

v3.23.1
Schedule of Reconciliation of Liabilities Measured at Fair Value (Details) - USD ($)
 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning Balance $ 198,519,395  
Issuance of warrants and contingent shares 243,681,478 $ 415,803,862
Change in fair value of warrants and contingent shares (166,379,348) $ 287,891,003
Beginning Balance 14,031,830  
Fair Value, Inputs, Level 3 [Member] | Warrant Liability [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning Balance 198,566,170  
Issuance of warrants and contingent shares 243,681,478  
Change in fair value of warrants and contingent shares (166,379,348)  
Warrants put back to Company for cash (33,886,612)  
Exercise of warrants (227,949,858)  
Beginning Balance 14,031,830  
Fair Value, Inputs, Level 3 [Member] | Purchase Consideration [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning Balance  
Issuance of warrants and contingent shares 23,250,000  
Change in fair value of warrants and contingent shares (15,328,124)  
Warrants put back to Company for cash  
Exercise of warrants  
Beginning Balance $ 7,921,876